Assessment of the effectiveness and safety of anti-VEGF/VEGFR monotherapy versus its combination with immune checkpoint inhibitors in advanced or metastatic renal cell carcinoma: a network meta-analysis - Poll - MDSpire

Assessment of the effectiveness and safety of anti-VEGF/VEGFR monotherapy versus its combination with immune checkpoint inhibitors in advanced or metastatic renal cell carcinoma: a network meta-analysis

  • By

  • Min Duan

  • Yanjun Liu

  • Kexin Qiao

  • Zuojing Li

  • Dongsheng Zong

  • January 21, 2026

  • 0 min

Share

Original Source(s)

Assessment of the effectiveness and safety of anti-VEGF/VEGFR monotherapy versus its combination with immune checkpoint inhibitors in advanced or metastatic renal cell carcinoma: a network meta-analysis

  • by Min Duan, Yanjun Liu, Kexin Qiao, Zuojing Li, Dongsheng Zong

  • January 21, 2026

Related Content

Synthetic short RNA in cancer

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma

Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure”